BT2A2_PONAB
ID BT2A2_PONAB Reviewed; 528 AA.
AC Q5R7W8;
DT 24-MAR-2009, integrated into UniProtKB/Swiss-Prot.
DT 21-DEC-2004, sequence version 1.
DT 25-MAY-2022, entry version 81.
DE RecName: Full=Butyrophilin subfamily 2 member A2;
DE Flags: Precursor;
GN Name=BTN2A2;
OS Pongo abelii (Sumatran orangutan) (Pongo pygmaeus abelii).
OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC Pongo.
OX NCBI_TaxID=9601;
RN [1]
RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA].
RC TISSUE=Brain cortex;
RG The German cDNA consortium;
RL Submitted (NOV-2004) to the EMBL/GenBank/DDBJ databases.
CC -!- FUNCTION: Inhibits the proliferation of CD4 and CD8 T-cells activated
CC by anti-CD3 antibodies, T-cell metabolism and IL2 and IFNG secretion.
CC {ECO:0000250}.
CC -!- SUBCELLULAR LOCATION: Membrane {ECO:0000305}; Single-pass type I
CC membrane protein {ECO:0000305}.
CC -!- PTM: N-glycosylated. {ECO:0000250}.
CC -!- SIMILARITY: Belongs to the immunoglobulin superfamily. BTN/MOG family.
CC {ECO:0000305}.
CC ---------------------------------------------------------------------------
CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC ---------------------------------------------------------------------------
DR EMBL; CR859991; CAH92142.1; -; mRNA.
DR RefSeq; NP_001126252.1; NM_001132780.1.
DR AlphaFoldDB; Q5R7W8; -.
DR SMR; Q5R7W8; -.
DR STRING; 9601.ENSPPYP00000018261; -.
DR GeneID; 100173224; -.
DR KEGG; pon:100173224; -.
DR CTD; 11120; -.
DR eggNOG; ENOG502QSRZ; Eukaryota.
DR InParanoid; Q5R7W8; -.
DR OrthoDB; 522383at2759; -.
DR Proteomes; UP000001595; Unplaced.
DR GO; GO:0016021; C:integral component of membrane; IEA:UniProtKB-KW.
DR GO; GO:0046007; P:negative regulation of activated T cell proliferation; ISS:UniProtKB.
DR GO; GO:0001818; P:negative regulation of cytokine production; ISS:UniProtKB.
DR Gene3D; 2.60.120.920; -; 1.
DR Gene3D; 2.60.40.10; -; 2.
DR InterPro; IPR001870; B30.2/SPRY.
DR InterPro; IPR043136; B30.2/SPRY_sf.
DR InterPro; IPR003879; Butyrophylin_SPRY.
DR InterPro; IPR013320; ConA-like_dom_sf.
DR InterPro; IPR007110; Ig-like_dom.
DR InterPro; IPR036179; Ig-like_dom_sf.
DR InterPro; IPR013783; Ig-like_fold.
DR InterPro; IPR003599; Ig_sub.
DR InterPro; IPR013106; Ig_V-set.
DR InterPro; IPR006574; PRY.
DR InterPro; IPR003877; SPRY_dom.
DR Pfam; PF13765; PRY; 1.
DR Pfam; PF00622; SPRY; 1.
DR Pfam; PF07686; V-set; 1.
DR PRINTS; PR01407; BUTYPHLNCDUF.
DR SMART; SM00409; IG; 1.
DR SMART; SM00406; IGv; 1.
DR SMART; SM00589; PRY; 1.
DR SMART; SM00449; SPRY; 1.
DR SUPFAM; SSF48726; SSF48726; 2.
DR SUPFAM; SSF49899; SSF49899; 1.
DR PROSITE; PS50188; B302_SPRY; 1.
DR PROSITE; PS50835; IG_LIKE; 1.
PE 2: Evidence at transcript level;
KW Coiled coil; Disulfide bond; Glycoprotein; Immunoglobulin domain; Membrane;
KW Reference proteome; Signal; Transmembrane; Transmembrane helix.
FT SIGNAL 1..29
FT /evidence="ECO:0000255"
FT CHAIN 30..528
FT /note="Butyrophilin subfamily 2 member A2"
FT /id="PRO_0000367055"
FT TOPO_DOM 30..249
FT /note="Extracellular"
FT /evidence="ECO:0000255"
FT TRANSMEM 250..270
FT /note="Helical"
FT /evidence="ECO:0000255"
FT TOPO_DOM 271..528
FT /note="Cytoplasmic"
FT /evidence="ECO:0000255"
FT DOMAIN 31..142
FT /note="Ig-like V-type"
FT DOMAIN 150..232
FT /note="Ig-like C2-type"
FT DOMAIN 311..507
FT /note="B30.2/SPRY"
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00548"
FT COILED 270..320
FT /evidence="ECO:0000255"
FT CARBOHYD 47
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 115
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT CARBOHYD 121
FT /note="N-linked (GlcNAc...) asparagine"
FT /evidence="ECO:0000255"
FT DISULFID 52..126
FT /evidence="ECO:0000255|PROSITE-ProRule:PRU00114"
SQ SEQUENCE 528 AA; 60060 MW; 818C23F038FE4E66 CRC64;
MESAAALHFS RPASLLLLLL LSLCALVSAQ VTVVGPTDPI LGMVGENTTL RCHLSPEKNA
EDMEVRWFRS QFSPAVFVYK GGRERTEEQM EEYRGRTTFV SKDISRGSVA LVIHNITAQE
NGTYRCYFQE GRSYDEAILH LIVAGLGSKP LIEMRGHEDG GIRLECISRG WYPKPLTVWR
DPYGGVVPAL KEVSMPDADS LFMVTTAVII RDKSVRNMFC SINNTLLSQK KESVIFIPES
FMPSVSPCAV ALPIVVVILM ILFAVCMYWI NKLQKEKKIL SGEKEFERET REIAVKELEK
ERVQKEEELQ VKEKLQEELR WRRTFLHAVD VVLDPDTAHP DLFLSEDRRS VRRRPFRHLG
ESMPDNPERF NSQPCVLGRE SFASGKHYWE VEVENVIEWT VGVCRDSVER KGEVLLIPQN
GFWTLEMHKS QYRAVSSPDR IIPLKESLCR VGVFLDYEAG DVSFYNMRDR SHIYTCPRSA
FSVPVRPFFR LGCEDSPIFI CPALTGANGV TVPEEGLTLH RVGTHQSL